Published in Reprod Biomed Online on August 21, 2003
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update (2010) 1.45
Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan. Reprod Med Biol (2013) 0.86
Estradiol progesterone ratio on ovulation induction day: a determinant of successful pregnancy outcome after intra cytoplasmic sperm injection. Iran J Reprod Med (2014) 0.85
Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome. J Assist Reprod Genet (2014) 0.83
Analyzing the possible involvement of anti-Müllerian hormone and anti-Müllerian hormone receptor II single nucleotide polymorphism in infertility. J Assist Reprod Genet (2013) 0.82
Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review. Mol Hum Reprod (2015) 0.77
Early initiation of gonadotropin-releasing hormone antagonist in polycystic ovarian syndrome patients undergoing assisted reproduction: randomized controlled trial ISRCTN69937179. J Assist Reprod Genet (2012) 0.77
Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2016) 0.75
PCOS women show significantly higher homocysteine level, independent to glucose and E2 level. Int J Reprod Biomed (Yazd) (2016) 0.75
Anovulation and ovulation induction. Hippokratia (2006) 0.75
Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med (2008) 4.33
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 3.57
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet (2007) 3.36
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med (2004) 2.95
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Anti-Müllerian hormone: a new marker for ovarian function. Reproduction (2006) 2.49
Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update (2004) 2.47
Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol (2005) 2.42
Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol (2002) 2.29
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab (2003) 2.26
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod (2007) 2.11
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril (2002) 1.78
The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev (2006) 1.75
Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet (2009) 1.72
Primary ovarian insufficiency. Lancet (2010) 1.67
The Ross procedure: a systematic review and meta-analysis. Circulation (2008) 1.65
Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol (2003) 1.63
Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab (2004) 1.61
Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? Ann Epidemiol (2005) 1.61
Prognosis after aortic root replacement with cryopreserved allografts in adults. Ann Thorac Surg (2003) 1.59
The international agreement study on the diagnosis of the septate uterus at office hysteroscopy in infertile patients. Fertil Steril (2013) 1.51
Prediction models in reproductive medicine: a critical appraisal. Hum Reprod Update (2009) 1.50
The impact of ovarian stimulation with recombinant FSH in combination with GnRH antagonist on the endometrial transcriptome in the window of implantation. Reprod Sci (2008) 1.50
A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet (2013) 1.50
Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol (2004) 1.46
Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med (2008) 1.44
Actual and actuarial probabilities of competing risks: apples and lemons. Ann Thorac Surg (2007) 1.43
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J Clin Endocrinol Metab (2007) 1.42
Risk of bilateral visual impairment in individuals with amblyopia: the Rotterdam study. Br J Ophthalmol (2007) 1.41
Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome. Hum Reprod (2013) 1.40
A reanalysis of a reanalysis! The path to enlightenment. Fertil Steril (2002) 1.40
Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab (2008) 1.39
A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment. Fertil Steril (2007) 1.38
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol Metab (2004) 1.37
The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population. Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.34
Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod (2004) 1.32
X chromosome inactivation is initiated in human preimplantation embryos. Am J Hum Genet (2009) 1.31
Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod (2007) 1.27
A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer. Fertil Steril (2002) 1.27
Female meiotic sex chromosome inactivation in chicken. PLoS Genet (2009) 1.26
Exacerbated innate host response to SARS-CoV in aged non-human primates. PLoS Pathog (2010) 1.26
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol (2012) 1.24
Balancing the strengths of systematic and narrative reviews. Hum Reprod Update (2004) 1.24
Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum Reprod (2007) 1.23
Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg (2009) 1.22
New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv (2002) 1.21
Heterogeneity bias: the difference between adjusted and unadjusted effects. Med Decis Making (2004) 1.20
A new logistic regression approach for the evaluation of diagnostic test results. Med Decis Making (2005) 1.19
Prediction model and prognostic index to estimate clinically relevant pelvic organ prolapse in a general female population. Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.18
Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update (2012) 1.18
Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol Metab (2008) 1.16
Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol (2008) 1.15
A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients. J Clin Endocrinol Metab (2008) 1.12
A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod (2007) 1.12
A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab (2007) 1.10
Renaming PCOS--a two-state solution. J Clin Endocrinol Metab (2013) 1.08
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
Tackling burden in ART: an integrated approach for medical staff. Hum Reprod (2012) 1.07
Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 1.07
Letter to the editor: gonadal function after childhood ovarian surgery. J Pediatr Surg (2013) 1.07
Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives. J Clin Epidemiol (2011) 1.07
Measuring patient-centredness, the neglected outcome in fertility care: a random multicentre validation study. Hum Reprod (2010) 1.07
Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril (2003) 1.06
A role for Aurora C in the chromosomal passenger complex during human preimplantation embryo development. Hum Reprod (2011) 1.05
Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies. Eur J Hum Genet (2008) 1.02
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril (2002) 1.02
High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod (2003) 1.01
Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod (2009) 1.01
A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine. BJU Int (2011) 1.00
Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management and immediate treatment. Hum Reprod (2011) 0.99
Prediction of an ongoing pregnancy after intrauterine insemination. Fertil Steril (2004) 0.99
Intraovarian control of early folliculogenesis. Endocr Rev (2014) 0.99
Predictive value and clinical impact of Basal follicle-stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab (2007) 0.98
Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg (2006) 0.98
Low folate in seminal plasma is associated with increased sperm DNA damage. Fertil Steril (2008) 0.98
Acceptable cost for the patient and society. Fertil Steril (2013) 0.97
Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update (2012) 0.97
Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update (2003) 0.96